DE2702058C2 - Arzneimittel mit hypolipidämischer Wirkung und p-Aminobenzoesäurederivate - Google Patents

Arzneimittel mit hypolipidämischer Wirkung und p-Aminobenzoesäurederivate

Info

Publication number
DE2702058C2
DE2702058C2 DE2702058A DE2702058A DE2702058C2 DE 2702058 C2 DE2702058 C2 DE 2702058C2 DE 2702058 A DE2702058 A DE 2702058A DE 2702058 A DE2702058 A DE 2702058A DE 2702058 C2 DE2702058 C2 DE 2702058C2
Authority
DE
Germany
Prior art keywords
aminobenzoic acid
compounds
medicinal products
acid derivatives
benzodioxol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2702058A
Other languages
German (de)
English (en)
Other versions
DE2702058A1 (de
Inventor
Bobbie Jewel Detroit Mich. Allen
Alfred Arthur Midland Mich. Renzi
Eugene Ross Midland Mich. Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Chemical Co
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of DE2702058A1 publication Critical patent/DE2702058A1/de
Application granted granted Critical
Publication of DE2702058C2 publication Critical patent/DE2702058C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
DE2702058A 1976-01-19 1977-01-19 Arzneimittel mit hypolipidämischer Wirkung und p-Aminobenzoesäurederivate Expired DE2702058C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65009076A 1976-01-19 1976-01-19

Publications (2)

Publication Number Publication Date
DE2702058A1 DE2702058A1 (de) 1977-07-28
DE2702058C2 true DE2702058C2 (de) 1985-09-19

Family

ID=24607411

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2702058A Expired DE2702058C2 (de) 1976-01-19 1977-01-19 Arzneimittel mit hypolipidämischer Wirkung und p-Aminobenzoesäurederivate

Country Status (14)

Country Link
JP (1) JPS5289660A (no)
AT (1) AT347923B (no)
AU (1) AU500881B2 (no)
BE (1) BE850516A (no)
CA (1) CA1072969A (no)
CH (1) CH628340A5 (no)
DE (1) DE2702058C2 (no)
DK (1) DK153471C (no)
FR (1) FR2338040A1 (no)
GB (2) GB1521459A (no)
IE (1) IE44858B1 (no)
NL (1) NL7700480A (no)
NO (1) NO145839C (no)
SE (1) SE435175B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0424904Y2 (no) * 1987-09-18 1992-06-12

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE716668C (de) * 1938-02-15 1942-01-27 Dr Aladar Skita Verfahren zur Herstellung von Derivaten substituierter Aminobenzoesaeuren
FR2080069A5 (no) * 1970-02-23 1971-11-12 Commissariat Energie Atomique
US3868416A (en) * 1973-10-01 1975-02-25 American Cyanamid Co Hypolipidemic 4-(monoalkylamino)benzoic acid derivatives

Also Published As

Publication number Publication date
NO770151L (no) 1977-07-20
FR2338040A1 (fr) 1977-08-12
AT347923B (de) 1979-01-25
BE850516A (fr) 1977-07-19
AU2114077A (en) 1978-07-13
IE44858L (en) 1977-07-19
NO145839B (no) 1982-03-01
IE44858B1 (en) 1982-04-21
NL7700480A (nl) 1977-07-21
CA1072969A (en) 1980-03-04
JPS5289660A (en) 1977-07-27
ATA31277A (de) 1978-06-15
FR2338040B1 (no) 1980-04-30
DK153471B (da) 1988-07-18
DK153471C (da) 1988-11-21
DK8177A (da) 1977-07-20
GB1521458A (en) 1978-08-16
SE7700490L (sv) 1977-07-20
JPS6233230B2 (no) 1987-07-20
AU500881B2 (en) 1979-06-07
GB1521459A (en) 1978-08-16
CH628340A5 (en) 1982-02-26
DE2702058A1 (de) 1977-07-28
SE435175B (sv) 1984-09-10
NO145839C (no) 1982-06-09

Similar Documents

Publication Publication Date Title
DE3486255T2 (de) Pharmazeutische Zusammensetzungen.
DE2414680C2 (de) Substituierte 2-Furancarbonsäuren und 2-Furancarbonsäureester, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
DE1445154B2 (de) 1,4-dihydro-1,8-naphthyridinderivate und ein verfahren zu ihrer herstellung
DE1795792A1 (de) Die serumlipoidkonzentration vermindernde arzneimittel
DE1770171C3 (de) 2,2-Dimethyl-7-alkyl-4-(4-pyridyl)-2H-chromen-5-ole, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneipräparate
DE2701854A1 (de) Hypolipidaemische p-benzylaminobenzoesaeuren und sie enthaltende mittel
DE2947624A1 (de) Beta, gamma -dihydropolyprenylalkohol und diesen enthaltendes blutdrucksenkendes arzneimittel
DE2323746A1 (de) Mono- und diester der 2,5-dihydroxybenzolsulfonsaeure
WO1981001285A1 (en) Substituted carboxylic ceto-acids,process for the preparation thereof,use thereof and medicinal compositions containing them
DE3617976A1 (de) 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
DE2251559C2 (de) 5,6-Dihydro-pyrrolo[3,4-b]pyridinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen
DE1593096B2 (no)
DE2702058C2 (de) Arzneimittel mit hypolipidämischer Wirkung und p-Aminobenzoesäurederivate
EP0027268A2 (de) Chinazolin-Derivate, Verfahren und Zwischenprodukte zu deren Herstellung, Arzneimittel enthaltend solche Chinazolin-Derivate und deren pharmazeutische Verwendung
DE2513136C3 (de) N-(1-Benzylpiperid-4-yl)-benzamide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
DE3438244C2 (no)
DE2428639A1 (de) Therapeutische mittel
DE3429227A1 (de) 1,3-dioxanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2412388A1 (de) Dibenzothiophenderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE2749520A1 (de) Harnstoffderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische und veterinaermedizinische zusammensetzungen
DE3925477A1 (de) Neue verbindungen der 3-isoxazolidinon-, 2h-1,2-oxazin-3-(4h)-on- und 3-isoxazepinon-serien
DE2725245A1 (de) Methylaminderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische oder veterinaermedizinische zusammensetzungen
DE2515142B2 (de) Oral verabfolgbare mittel zur senkung des lipid- und cholesterin- spiegels
AT360541B (de) Verfahren zur herstellung von neuen nicotinamido- und nicotinamidoalkylbenzoesaeuren und deren derivaten
DE2027577C3 (de) Glyzirrhetinsäureester, ihre Herstellung und diese enthaltende, pharmazeutische Zubereitungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee